September is Reproductive Cancer Awareness Month

Share Article

The Reproductive Cancer Awareness Month affects both men and women. It is a great reminder to take care of ourselves and to take precaution when it comes to our health.

News Image

September is recognized as “Reproductive Cancer Awareness Month” by many organizations, including the American Cancer Society (http://www.cancer.org/myacs...), in an effort to educate and inform the public. Ovarian and prostate cancer, two of the leading cancers in women and men respectively, are a focus for this month, making it a good reminder for patients to see their gynecologist and urologist for an annual check-up. We asked two of our highly praised “NJ Top Docs”, Drs. Hetal Gor of Women’s Own OB/GYN and Robert J. Rubino of The Rubino OB/GYN Group, to offer their professional opinions below:

Gynecologic cancer is cancer of the female reproductive system, which includes cervical cancer, endometrial/uterine cancer, ovarian cancer, vaginal cancer, vulvar cancer and peritoneal cancer. In the last two decades, considerable gains have been made in the detection and treatment of these cancers. When detected in the early stages, most gynecologic cancers have an excellent cure rate (http://www.cpmc.org/services/women...). When regular check-ups are not part of an annual recourse, these cancers can appear as an unexpected diagnosis.

Ovarian cancer is often called the “whisper” disease as it has few early symptoms and is most often detected in an advanced stage, when it has become less treatable and more widespread. As a result, the mortality rate from ovarian cancer exceeds that for all other gynecologic cancers combined and is the fourth most frequent cause of death in women in the United States.

Dr. Rubino shares, “Urinary frequency is one of the 'whispers' of ovarian cancer, in addition to subtle and persistent bloating. Most patients’ conditions are often suspected based on the history of their symptoms. When they share these complaints, it is often the only clue a physician has for suspected ovarian cancer. One of the best tools we have is a patient listening to their body, and in turn, we as doctors listen to our patients at the annual visit. These are the priorities for patient exams until a better screening option for ovarian cancer is developed.”

Dr. Gor adds, “Ovarian cancer is a silent killer. There are no specific symptoms which are diagnostic of ovarian malignancy. Patients may complain of bloating, flatulence, change in bowel habits, abdominal distention, unexplained weight loss, etc. Taking a detailed patient history, paying attention to risk factors and evaluating family history are important tools.”

“In my opinion, the recent coverage of the American College of Physicians (ACP) stating annual gynecological exams are unnecessary is in direct opposition to the American College of Obstetricians/Gynecologists (ACOG) that believes the annual visit to the gynecologist is perhaps the only opportunity a woman may have to detect ovarian cancer, bladder issue, sexual dysfunction and reproductive concerns. While it is uncommon to pick up a new ovarian cancer on a pelvic exam, the patient's innocuous complaints such as recent concern of onset urinary frequency will help trigger a work-up for ovarian cysts, typically inclusive of an ultrasound,”explains Dr. Rubino.

Approximately seventy percent of women diagnosed with ovarian cancer have advanced stages of the disease and about one in seventy women in the United States will develop ovarian cancer. It can occur at any age, even in childhood, but is most common after menopause.

The disease accounts for about 20,000 new cases and 12,500 deaths in the United States annually (http://www.cpmc.org/services/women). Some of the risk factors for developing ovarian cancer include previous diagnosis of breast cancer, family history of ovarian cancer, early menses, late menopause, and no children. Many women are under the false impression that the Pap Smear test detects ovarian cancer,. In fact, there is no current reliable diagnostic test for the cancer. Women must be aware of what their bodies might be telling them, schedule yearly visits with their physiciansand understand their family history.

The Ovarian Cancer Research Fund released a news article titled “Promising New Approach for Early Detection of Ovarian Cancer”. It states that researchers at M.D. Anderson Cancer Center in Houston have published new findings that show evaluating the change of CA-125, or “Cancer Antigen 125” - a protein that may be found in high amounts in the blood of patients with ovarian cancer (http://www.ocrf.org/news), over time shows promise as a screening tool for early-stage ovarian cancer. Although encouraging, these recent findings are not going to change clinical practice immediately asmore data is necessary before doctors use this method as a screening test. Dr. Gor adds, “There is no approved screening test yet but the combination of a a bimanual pelvic exam, transvaginal sonogram and Ca125 is often used for high risk patients for detection.”

Prostate cancer is the second leading cause of cancer death among men. When detected early, it results in high survival rates. The five-year survival rate is close to one-hundred percent. One in six men will be diagnosed with prostate cancer during his lifetime and one out of thirty-four will die of the disease. The American Cancer Society states on their website that African-American men are disproportionately affected by prostate cancer, having higher rates of diagnosis and death than men of all other racial or ethnic groups in the U.S. Almost one-third of prostate cancer cases are found in men during middle age.

The American Cancer Society urges that men know the facts on prostate cancer and understand their risks. They recommend men receive information from their health care provider about prostate cancer including the uncertainties, risks, and potential benefits associated with screening. Men at average risk should start talking to their doctors beginning at age 50. Men at higher risk should talk to their doctor about prostate testing earlier, including African Americans age 45 and older, and men with a first-degree relative diagnosed with prostate cancer should be screened at age 40.

The Reproductive Cancer Awareness Month affects both men and women. It is a great reminder to take care of ourselves and to take precaution when it comes to our health.

Dr. Hetal Gor provides comprehensive gynecologic care which includes but not limited to adolescent, peri-menopause and menopausal care in Bergen County. To learn more about Dr. Gor and her practice, click on the following link:
http://www.njtopdocs.com/DrGor

Dr. Robert J. Rubino of The Rubino OB/GYN Group of northern New Jersey offers the most advanced, non-invasive solutions to women’s health issues in a welcoming and patient-centered environment. To learn more about Dr. Rubino and his practice, click on the following link:http://www.njtopdocs.com/RubinoOBGYN

Sources

American Cancer Society
http://www.cancer.org/myacs/eastern/areahighlights/newsroom-prostate-awareness

Ovarian Cancer Research Fund
http://www.ocrf.org/

Facing Cancer Together
http://facingcancertogether.witf.org/healthy-lifestyle/september-is-gynecologic-cancer-awareness-month-9911

Sutter Health CPMC
http://www.cpmc.org/services/women/health/Gyn-cancers.html

About Us
NJ Top Docs is a comprehensive information resource of Top Doctors, Dentists and Hospitals. We are profiling over 900 Healthcare Providers and have made it convenient for you to find them.

NJ Top Docs allows patients to “meet” these providers online before making their appointment.

For more information, please visit http://www.NJTopDocs.com.

You can also follow us on Facebook – Twitter – YouTube

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cristina Mendez
NJ Top Docs
+1 (908) 288-7240 Ext: 100
Email >

Cristina Mendez
Visit website

Media